Introduction The ability for medical and research scientists around the globe to share data has enhanced the progress of medical discovery and healthcare delivery. Instant access to information via cloud-based technology by researchers and healthcare providers allows more time spent acting on and processing data. However, large bodies of data (aka “big data”) generated through […]
Introduction Aging has been accepted as a normal biological process that is inevitable. This deterioration of structure and function and loss of homeostasis over time is considered to some to be a collection of pathological processes or disorders that can be slowed or stopped. The search for the fountain of youth is ageless. Studies in […]
Introduction and Brief overview of NGS An important technological advance in the practice of diagnostic and clinical medicine is next-generation sequencing (NGS). This technology is rapidly transforming clinical practice by providing a means to obtain both diagnostic and prognostic data with the same data. This transformation is made possible because of the cost-effective and rapid […]
Next Generation Sequencing (NGS) has seen massive growth as the demand for low-cost sequencing has exploded. Information on NGS, though, is highly technical, and it’s important to go to the right sources to discuss the varying technologies in the field. These are the top 5 Next Generation Sequencing forums in 2016: SEQanswers SEQanswers is […]
Macrogen Corp., one of the leading providers of next-generation sequencing services, has been announced as a participating provider in precisionFDA. The precisionFDA web platform is part of President Obama’s vision with his Precision Medical Initiative announced last year. The administration’s goal is to move away from a “one-size-fits-all” approach to medicine and move towards a […]
The emergence and growth of whole genome sequencing technologies, and the resulting immense database generated, requires that scientists and medical professionals learn more about the powerful tools available to them. These tools give scientists the ability to interpret and apply the information and are becoming increasingly available. Genomic technologies have bolstered the power of personalized […]
Macrogen has recently partnered with N-of-One, a leader in clinical interpretation, with the goal of delivering high-level clinical interpretation for its newly launched clinical next-generation sequencing panels. N-of-One enables laboratories to save time and money while scaling their molecular diagnostics programs. It also provides therapeutic options to client organizations for thousands of cancer patient cases. […]
Introduction The newest sequencing technologies are providing new insights into disease etiology, individual susceptibilities, keys to drug discovery, and more. However, there are many questions and challenges regarding how to understand the meaning and applicability of the newfound wealth of data. As new data is generated at record rates, scientists are working diligently on the […]
Macrogen recently partnered with Edico Genome to reinforce its Bio-IT infrastructure with new DRAGEN processors. By deploying several DRAGEN Bio-IT Processors, which are designed and manufactured by Edico Genome, Macrogen will be able to provide faster processing and analysis of high-throughput NGS data. Accurate DNA sequencing and genomic analysis is reliant on advanced technology. To […]
The Genome Asia 100K Initiative announcement made big waves earlier this year as it is the first significant pan-Asian endeavor with the goal of creating a comprehensive genomic database. The initiative is similar to the 100K Genome Project in the United Kingdom and the US Precision Medicine Initiative. The Genome Asia 100K initiative is led […]
Psomagen, Inc. (previously Macrogen Corp.), established in 2004, offers “total genomic solutions” for both clinical and research purposes, mainly focusing on end-to-end sequencing services. The company will expand its services to include personal DNA tests.
inquiry@nullpsomagen.com
(301) 251-1007
ROCKVILLE, MARYLAND (HQ)
CLIA: 21D2062464 | CAP: 8742212
BROOKLYN, NEW YORK
CAMBRIDGE, MASSACHUSETTS
STERLING, VIRGINIA
CLIA: 49D2172599
KOSDAQ: PSOMAGEN INC (950200)
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
OK